Description Opthea
Opthea is an Australian biopharmaceutical company focused on developing therapies for retinal eye diseases. Its lead program, sozinibercept, targets vascular endothelial growth factor pathways for conditions such as wet age-related macular degeneration and diabetic macular edema.